Myrexis, Inc. Share Price Other OTC
Equities
MYRX
US62856H1077
Biotechnology & Medical Research
Sales 2012 | - | Sales 2013 | - | Capitalization | 2.59M 216M |
---|---|---|---|---|---|
Net income 2012 | -31M -2.59B | Net income 2013 | -11M -918M | EV / Sales 2012 | - |
Net cash position 2012 | 89.38 7.46K | Net cash position 2013 | 1.21 100.93 | EV / Sales 2013 | - |
P/E ratio 2012 |
-2.21
x | P/E ratio 2013 |
-0.19
x | Employees | - |
Yield 2012 * |
-
| Yield 2013 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 22/13/22 | |
Gary S. Mather
PRN | Corporate Officer/Principal | - | 01/01/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 22/13/22 |
1st Jan change | Capi. | |
---|---|---|
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |